Attenuation Of Hemodynamic Response To Laryngoscopy. Role Of Dexmedetomidine. A Dose Finding Study
Status:
Completed
Trial end date:
2021-12-13
Target enrollment:
Participant gender:
Summary
Two doses of Dexmedetomidine (0.5 µ/kg and 0.75 µ/kg) will be used to attenuate the stress
response to laryngoscopy in American Society of Anesthesiology, physical class I patients
which will be compared with the placebo-controlled group.